값202020212022202320242025TTM투자 활동으로 인한 현금-58.8 M-175.34 M109.59 M87.36 M104.07 M14.04 M16.73 M재무활동으로 인한 현금465.28 M211.5 M81.84 M5 M51.48 M53.05 M52.98 M잉여 현금 흐름-177.98 M-215.71 M-216.22 M-124.37 M-104.08 M-88.63 M-83.35 M
Inovio Pharmaceuticals, Inc. - Common Stock
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.